Header Logo

Connection

BANU K ARUN to Receptor, ErbB-3

Back to Details
This is a "connection" page, showing publications BANU K ARUN has written about Receptor, ErbB-3.
BANU K ARUN
Connection Strength
0.020
Receptor, ErbB-3
  1. A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer. Cancer Chemother Pharmacol. 2009 Nov; 64(6):1139-48.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.